← Leaderboards
Julie-Aurore Losman
Dana-Farber Cancer Inst
$3,002,683
Attributed
$3,002,683
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $631.7K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,002,683 · 3
By mechanism
R01$1,902,243 · 1
R00$747,000 · 1
K99$353,440 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Matthew G. Vander Heiden$15,877,095
- Kornelia Polyak$28,582,691
- Tracy T Batchelor$27,819,477
- Alexander H. Stegh$12,620,634
- Benjamin Levine Ebert$26,802,844
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantMutationFamilyIn VitroMalignant - DescriptorMouse ModelComplementary DnaDysmyelopoietic SyndromesHematopoiesisInsightIn VivoLeukemiaMalignant NeoplasmsMediatingAffectCombined Modality TherapyCytokineCell LineBaseCellsCell TransformationHematopoietic Stem CellsAlpha KetoglutarateMyelogenous
Grant awards (10)
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors$382,745
R01 · FY2022 · CA · contact PI
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors$382,745
R01 · FY2021 · CA · contact PI
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors$382,745
R01 · FY2020 · CA · contact PI
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors$371,263
R01 · FY2019 · CA · contact PI
KDM5 histone lysine demethylases as potential novel myeloid tumor suppressors$382,745
R01 · FY2018 · CA · contact PI
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia$249,000
R00 · FY2018 · CA · contact PI
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia$249,000
R00 · FY2017 · CA · contact PI
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia$249,000
R00 · FY2016 · CA · contact PI
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia$176,720
K99 · FY2015 · CA · contact PI
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia$176,720
K99 · FY2014 · CA · contact PI